1 ompression by combining a transobturator and suprapubic approach has recently been introduced, with t

2 ns between the Tension-free Vaginal Tape and Suprapubic Arch sling procedure demonstrate no significa

3 sling procedures (tension-free vaginal tape, suprapubic arch, transobturator tape) has dramatically a

4 thral catheter (TUC), and urine collected by suprapubic aspirate (SPA), regardless of whether the sub

5  ureteral stent attached to a large diameter suprapubic catheter was removed in a joint manner withou

6                             After removal of suprapubic catheters and ureteral stents, all patients w

7 ine samples by voided, transurethral, and/or suprapubic collection methods.

8 -like symptoms such as perineal, penile, and suprapubic discomfort or pain during or after ejaculatio

9 s, malaise, lethargy, flank pain, hematuria, suprapubic discomfort, dysuria, and urgent or frequent u

10 ng vaginal discharge, vaginal pain/pressure, suprapubic pain, and recurrent urinary tract infection.

11             A palpable mass was noted in the suprapubic region, and a second mass was palpated in the

12 ), and no difference in right iliac fossa or suprapubic site-specific pain scores, opioid use, recove

13 al tape (TVT), trans-obturator tape (TOT) or suprapubic sling (SS) surgical mesh procedures between A

14 r than 40 degrees C (LR range, 3.2-3.3), and suprapubic tenderness (LR, 4.4; 95% confidence interval

15 urinary urgency or frequency, acute dysuria, suprapubic tenderness, or costovertebral angle pain or t